Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation

Toxicology and Applied Pharmacology

Volumn 175, Issue 3, 2001, Pages 260-268

  Chen, Hua ^a   Liu, Jie ^a   Zhao, Christopher Q ^a   Diwan, Bhalchandra A ^b   Merrick, Bruce A ^a   Waalkes, Michael P ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Arsenic; Arsenic induced malignant transformation; C myc activation; Hyperproliferation

Indexed keywords

ARSENIC TRIOXIDE;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; DNA METHYLATION; GENE ACTIVATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; LIVER CANCER; MALIGNANT TRANSFORMATION; METASTASIS; MOUSE; NONHUMAN; ONCOGENE C MYC; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALIA; MUS MUSCULUS;

EID: 0035884036     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.2001.9253     Document Type: Article

References (51)

1. Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity
2. Alterations in DNA methylation: A fundamental aspect of neoplasia
3. Tumorigenic conversion of immortal human skin keratinocytes (HaCaT) by elevated temperature
4. Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms
5. Genetic events associated with arsenic-induced malignant transformation: Applications of cDNA microarray technology
6. Alterations in DNA methylation may play a variety of roles in carcinogenesis
7. Toxicological and pathological applications of proliferating cell nuclear antigen (PCNA), a novel endogenous marker for cell proliferation
8. Signal transduction. Beating a path to Myc
9. Expression of proliferating cell nuclear antigen and CD44 variant isoforms in the primary and metastatic sites of nonsmall cell lung carcinoma with intrapulmonary metastases
10. Arsenic induces overexpression of growth factors in human keratinocytes
11. Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors
12. Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors
13. Function of a human cyclin gene as an oncogene
14. Cooperation between oncogenes
15. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression
16. Function of the c-Myc oncoprotein
17. Amplification of c-myc in hepatocellular carcinoma: Correlation with clinicopathologic features, proliferative activity and p53 overexpression
18. Recent advances in arsenic carcinogenesis: Modes of action, animal model systems, and methylated arsenic metabolites
19. DNA methylation and gene expression: Introduction and overview
20. Drinking water arsenc in Utah: A cohort mortality study
21. Requirement for PCNA and RPA in interstrand crosslink-induced DNA synthesis
22. Induction of oxyradicals by arsenic: Implications for mechanism of genotoxicity
23. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: Link between cell cycle control and malignant transformation
24. Myc represses the growth arrest gene gadd45
25. Arsenic alters cytosine methylation patterns of the promoter region of the tumor suppressor gene p53 in human lung cells: A model for a mechanism of carcinogenesis
26. Evaluation of argyrophilic nucleolar organizer region and proliferating cell nuclear antigen in colorectal cancer
27. Metabolism of c-myc gene products: C-myc mRNA and protein expression in the cell cycle
28. Studies on hypomethylation of liver DNA during early stages of chemical carcinogenesis in rat liver
29. Absence of arsenite mutagenicity in E coli and Chinese hamster cells
30. Tissue microarrays for gene amplification surveys in many different tumor types
31. Correlation between DNA methylation and pathological changes in human hepatocellular carcinoma
32. Hypomethylation of DNA in ethionine-fed rats
33. Hepatic DNA methylation and liver tumor formation in male C3H mice fed methionine- and choline-deficient diets
34. Correlation between S-adenosyl-L-methionine content and production of c-myc, c-Ha-ras, and c-Ki-ras mRNA transcripts in the early stages of rat liver carcinogenesis
35. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo
36. Cyclin D1 as a cellular proto-oncogene
37. Neoplastic transformation of mouse mammary epithelial cells by deregulated myc expression
38. Transgenic mouse models in carcinogenesis: Interaction of c-myc with transforming growth factor alpha and hepatocyte growth factor in hepatocarcinogenesis
39. The role of DNA hypermethylation in human neoplasia
40. Sodium arsenite-induced dysregulation of proteins involved in proliferative signaling
41. Hypomethylation of CpG sites and c-myc gene overexpression in hepatocellular carcinomas, but not hyperplastic nodules, induced by a choline-deficient L-amino acid-defined diet in rats
42. PCNA binding proteins
43. Methylation of inorganic arsenic in different mammalian species and population groups
44. Induction of proliferative lesions of uterus, testes and liver in Swiss mice given repeated injections of sodium arsenate: Possible estrogenic mode of action
45. Forum metals and disorders of cell accumulation: Modulation of apoptosis and cell proliferation
46. Methyl groups in carcinogenesis: Effects on DNA methylation and gene expression
47. Changes of DNA methylation in protooncogenes in the process of radiation-induced transformation of mouse m5S/1M cells in vitro
48. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression